Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |